Does THIOTEPA Cause Product use in unapproved indication? 425 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 425 reports of Product use in unapproved indication have been filed in association with THIOTEPA (Thiotepa). This represents 6.2% of all adverse event reports for THIOTEPA.
425
Reports of Product use in unapproved indication with THIOTEPA
6.2%
of all THIOTEPA reports
86
Deaths
63
Hospitalizations
How Dangerous Is Product use in unapproved indication From THIOTEPA?
Of the 425 reports, 86 (20.2%) resulted in death, 63 (14.8%) required hospitalization, and 22 (5.2%) were considered life-threatening.
Is Product use in unapproved indication Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for THIOTEPA. However, 425 reports have been filed with the FAERS database.
What Other Side Effects Does THIOTEPA Cause?
Off label use (762)
Febrile neutropenia (645)
Mucosal inflammation (616)
Cytomegalovirus infection (446)
Pyrexia (359)
Drug ineffective (358)
Acute graft versus host disease in skin (355)
Acute graft versus host disease (331)
Cytomegalovirus infection reactivation (325)
Infection (318)
What Other Drugs Cause Product use in unapproved indication?
DUPILUMAB (33,452)
DICLOFENAC (12,197)
METHOTREXATE (8,930)
PREDNISONE (7,625)
RITUXIMAB (7,519)
MYCOPHENOLATE MOFETIL (5,910)
ACETAMINOPHEN (5,819)
CYCLOPHOSPHAMIDE (5,750)
RISPERIDONE (5,551)
TACROLIMUS (5,057)
Which THIOTEPA Alternatives Have Lower Product use in unapproved indication Risk?
THIOTEPA vs THIOTHIXENE
THIOTEPA vs THROMBIN
THIOTEPA vs THROMBIN HUMAN
THIOTEPA vs THYMOCYTE IMMUNE GLOBULIN NOS
THIOTEPA vs THYMOGLOBULINE